Clinical Trial Update: Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

View source ↗

Summary

A clinical trial protocol evaluating integrated phenotyping of the gut-platelet-liver axis to understand progression of chronic liver disease, including NAFLD a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: Stefania Basili | Conditions: Non-alcoholic Fatty Liver Disease (NAFLD), NASH - Nonalcoholic Steatohepatitis | Status: NOT_YET_RECRUITING